The Treatment of Hypertension: A Fifteen-Year Follow-up * by Leonard, John C.
THE TREATMENT OF HYPERTENSION:
A FIFTEEN-YEAR FOLLOW-UP*
JOHN C. LEONARDt
In 1936 the late Dr. Francis G. Blake encouraged me to work with my
surgical colleague, Dr. Ashley W. Oughterson, in the selection of patients
for the surgical treatment of hypertension and in their subsequent post-
operative course. The patients, twelve in number, were treated surgically
by one of us (A.W.O.) by subdiaphragmatic splanchnic resection between
1937 and 1940 and were reported in detail in 1941.2'
Of these original twelve patients (eight female and four male), the ages
ranged from twenty-three to fifty-three years; eleven were white and one
was colored. The blood pressure ranged from 250 to 300+ mm. Hg. systolic
and 120 to 170 mm. Hg. diastolic pressure in the females with the excep-
tion of one, in whom the original pressure was 180/105. In the males the
pressure ranged from 230 to 270 mm. Hg. systolic and 130 to 165 mm. Hg.
diastolic pressure with the exception of one patient in whom the original
blood pressure was 160/105. Of this entire group the hypertension had
returned to its preoperative level in each instance within six to twelve
months and now, twelve to fifteen years later, there are only three sur-
vivors, all females. Each of the survivors has severe hypertension despite
the fact that one of them was operated upon again (lumbo-dorsal sympa-
thectomy) five years ago.
Eight of these twelve patients were younger than forty years of age at
the time of operation and three of the four males were under the age of
forty. Two of the males died within eight and fourteen months, one three
years and one four and a half years postoperatively. No patient in this
group had any truly objective postoperative improvement. All of the four
male patients were considered to have "malignant" hypertension, while four
of the eight female patients were so designated.
Since 1940 it has been my privilege to follow closely an additional forty
patients who were surgically treated by the more extensive thoraco-lumbar
sympathetic resection of the Smithwick variety.' This group was operated
upon in the period from 1940 to 1947 and is composed of twenty-six females
and fourteen males, with ages varying between twenty-two and fifty-four
years. Of this latter group there is only one survivor among the males and
fifteen survivors among the females. Of this group, twelve of twenty-six
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females and six of fourteen males gave evidence of "malignant" hyperten-
sion when first seen. Of those with "malignant" hypertension there are
three survivors of twelve patients among the females and only one of the
six among the males. The blood pressure ranged from 240 to 300+ mm. Hg.
systolic and 120 to 180 mm. Hg. diastolic pressure in the females and from
230 to 280 mm. Hg. systolic and from 130 to 170 mm. Hg. diastolic press-
ure in the males. In this entire group of forty patients the blood pressure
has returned to preoperative, hypertensive levels within six to twenty-four
months and there has been little, if any, objective evidence of improvement.
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Operative Criteria
In our previous study' we stated: "The criteria for suitable patients for
this operation (sympathectomy) are not well defined." This statement is
still true for, despite many diagnostic and prognostic criteria that have come
and gone, none has proven of any real value in selecting those patients who
might be expected to do well postoperatively. In general, such patients
probably should be limited to those no older than fifty or fifty-five years of
age and preferably to the twenty- to forty-year age group. Renal function
should be unimpaired and the patient, if in heart failure, should be brought
into cardiac compensation.
The Hypertensive Survey
Since there is a small percentage of hypertensive patients who may be
dramatically cured surgically, every group of hypertensives should be
searched carefully for one of the following causes of curable hypertension:
(1) Brain tumor with "central" hypertension
(2) Coarctation of the aorta
(3) Pheochromocytoma of the adrenal medulla
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(4) Adrenal cortical tumor
(5) Unilateral renal disorder, provided the remaining kidney is
normal.
It should go without saying that for every patient with hypertension,
whether or not surgical therapy is contemplated, the following information
should be secured:
(1) A carefully taken medical history which should include:
(a) Family history
(b) Marital history
(c) Occupational history
(d) Socio-economic history
(e) Emotional history, including habits relating to drugs, tobac-
co, alcohol, and recreation
(2) A complete physical examination with particular attention to:
(a) The eyegrounds
(b) The heart
(c) The vascular system
(d) The kidney regions
(e) The blood pressure measurement early and late in the exam-
ination and under variable states of emotional tension and
relaxation. It is well at all times during such an examina-
tion to de-emphasize to the patient the importance of the
level of the blood pressure.
(3) An X-ray and laboratory examination which should include:
(a) X-ray of the chest for cardiac size and shape and to rule out
coarction of the aorta.
(b) Electrocardiogram. This is particularly important if serial
E.K.G.'s can be taken over a period of years. The ballisto-
cardiogram may be added as a supplementary aid when
indicated.
(c) X-ray of the abdomen with particular attention to the kidney
region (calculi, polycystic kidneys, etc.)
(d) An intravenous pyelogram and occasionally one must resort
to retrograde pyelography for optimum visualization of
the urinary tract.
(e) X-ray of the skull may prove helpful but is not routinely
necessary.
(f) Urinalysis with particular attention to albuminuria and to
the urine sediment. Addis counts may be helpful as a guide
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in renal disease activity if they are performed by the same
individual or by a small group of careful microscopists.
(g) Renal function may be measured grossly by the specific grav-
ity and P.S.P. dye excretion and more adequately by the
urine concentration and dilution tests. An N.P.N. or
B.U.N. determination should be made on the blood since
occasionally one may find elevation in the absence of al-
buminuria or abnormalities of the urine sediment. Urea
clearance and other more complicated tests of renal func-
tion should be reserved for those patients where such study
is indicated.
(h) Urine culture. This should always be routine in the work-up
of hypertensives since much hypertension, especially in
young females, is based upon pyelonephritis and frequently
may be cured with antibiotics or chemotherapy.
The X-ray and laboratory survey should attempt to rule out
acute or chronic glomerular nephritis, chronic pyelonephri-
tis with extensive and permanent renal damage, amyloid
disease of the kidney, congenital polycystic kidneys, abber-
ant renal blood vessels, bilateral hydronephrosis (with or
without calculi) secondary to long-standing lower urinary
tract obstruction, since these conditions, among others, may
cause hypertension.
Symptoms
It is quite well recognized that there are likely to be no symptoms of
hypertension until the complications of hypertension express themselves by
way of abnormalities in the retinal and cerebral vessels, the coronary or
the renal circulation. It generally is conceded that headache is not a com-
mon symptom of hypertension until after the patient has been told that he
has high blood pressure. This also is often true of such symptoms as ner-
vousness, fatiguability, dizziness, tightness or pain in the occipital and
posterior cervical region, insomnia, palpitation, and even precordial pain.
These are among the classical symptoms of anxiety which so often are
iatrogenic in origin.
Therapy
The variety of surgical operations, including the ultraradical adrenalec-
tomy, that have heen designed to correct hypertension, and the multitude
of drugs and medical measures that have been used attest to the fact that as
yet we do not have the answer. Many of my readers have witnessed the
waves of enthusiasm that followed the introduction of the vasodilators, the
thiocyanates, the various low-calorie, low-salt, and low-protein diets, pyro-
gen therapy, the cyclic re-introduction of the veratrum alkaloids, and now,
510TREATMENT OF HYPERTENSION
more recently, the sympathetic ganglion-blocking agents such as tetraethyl-
ammonium chloride, penta- (C5) and hexamethonium (C6) bromide and
iodide, the homologue of hexamethonium (M & B 1863) and other com-
pounds such as hydrazinophthalazine (Apresoline C-5968) and the hydro-
genated alkaloids of the ergotoxine group (Hydergine).
While there are many who still are enthusiastic about the therapeutic
value of the veratrum compounds, this group of drugs is difficult to control
in clinical therapy. The incidence of toxicity is high and the toxic and
therapeutic doses are separated by only a narrow margin of safety. It is
doubtful whether their use should be attempted by the inexperienced. It
also does not seem that the course of an appreciable number of hypertensive
patients has been altered by this form of therapy.3"'0' '.. " 4a
During the past two years there has been increasing enthusiasm regard-
ing the use of several members of the methonium group of drugs with their
ability to perform a chemical sympathectomy by means of their ganglionic
blocking properties.462 Pentamethonium (C5) and hexamethonium
(C6) have received the greatest amount of attention. However, because of
the inconstancy of dosage and the irregularity of absorption and individual
response, we feel that these drugs may prove disappointing in the therapy
of the hypertensive patient.2"
It should be emphasized that in the treatment of either essential or
malignant hypertension many writers claim a very high incidence of symp-
tomatic relief for their patients with the particular form of treatment that
they recommend, frequently without relating this improvement to any ob-
jective decrease in blood pressure. As one reviews the literature on this
subject it appears that almost any form of therapy produces an objective
drop in blood pressure in approximately 25 per cent and a symptomatic
improvement in 50 to 75 per cent of patients. This degree of subjective
improvement is not rare even when a placebo is used!
In the present state of our lack of understanding of hypertension it might
well be harmful to stress the value of any potentially dangerous form of
therapy when subjective improvement so often occurs with a placebo
administered with enthusiasm and confidence on the part of the physician.
I should like to offer the thought that hypertensive patients who survive
for long periods of time are not necessarily alive because of the surgical or
medical treatment of their hypertension but perhaps occasionally in spite of
the therapy that they have received!
Order of Choice in Therapy of Hypertension
(Following careful investigation of the patient)
GROUP OF CHOICE
(1) Superficial psychotherapy of sympathetic understanding and "good
listener" variety by the family physician or the internist, the psychiatrist
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to be asked for assistance only in those few who do not respond well, or
moderately well, to the above.
(2) Rest. Reasonable physical rest and removal from, or alleviation of,
emotional stress wherever and whenever possible. Prolonged bed rest is
usually impractical and economically impossible.
(3) Mild sedation, eg. phenobarbital, grs. Y4, b.i.d., t.i.d., or q.i.d.,
especially during periods of emotional stress.
(4) Weight reduction for the obese.
(5) Low sodium diet for those who have cardiac or renal involvement.
Beware of low sodium diet in excessively hot weather, in vomiting, diar-
rhea, or in renal "salt wasters."
GROUP OF LESS VALUE
(1) Veratrum alkaloids. These drugs are quite toxic and difficult to
control.
(2) Methonium compounds. Their action is irregular and reactions are
dangerous.
(3) Pyrogen therapy. This treatment is usually impractical because a
long period of hospitalization is necessary.
GROUP OF LEAST VALUE
(1) Thoraco-lumbar sympathectomy. This should be reserved for those
unusual patients who, despite other more reasonable forms of therapy, con-
tinue a downhill course in "malignant" hypertension. This should constitute
a very small percentage of the entire group.
(2) Adrenalectomy. Impractical and impossible beyond constant hospi-
tal or research control.
DISCUSSION
Cardiovascular disease ranks number one as the arch enemy and killer
of the human race. Hypertension, sometimes called a disorder of "civiliza-
tion," is commonly associated with cardiac disease, renal disease, and
arteriosclerosis but frequently is present, as essential hypertension, in their
absence.
Since the maintenance of normal arterial pressure is regulated by a highly
intricate and carefully integrated mechanism that is probably controlled
through the central nervous system, it is not too much to expect that ele-
vated arterial pressure may be brought about by interference with the
regulatory mechanism at the level of the central nervous system, the
autonomic nervous system, the vascular system, or the endocrine system by
way of the hormonal and chemical imbalance contributed to by the pituitary
gland and the cortex and medulla of the adrenal gland. This regulatory
mechanism may be influenced also by the kidney. A patient with hyper-
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tension, therefore, may appear to have his elevated blood pressure on an
emotional, neurogenic, endocrine, humoral, chemical, metabolic, cardiac,
vascular or renal basis, or on the basis of any combination of these.
It is now thought by many that the stimuli that may upset the blood
pressure regulatory mechanism may come from the patient's external en-
vironment in the form of emotional trauma. This succession of emotional
traumata may cause temporary or sustained elevation of pressure and
eventually may affect the patient's entire internal environment. Since our
physical and emotional make-up is so highly dependent upon the combina-
tion of the impact of our heredity and our environment, it is little wonder
that the cause of hypertension in any one patient may be single or multiple
and that hypertension may result from a single event or from a varied suc-
cession of events. These tend at first intermittently and later continuously
to raise arterial pressure. Eventually perhaps as part of a process of adapta-
tion, the central integrating mechanism controlling the basal arterial press-
ure may become set at a higher level, thereby establishing a vicious cycle
of pathological physiology. Furthermore, it is possible that the number of
inciting and/or perpetuating factors may increase or decrease as time goes
on so that in some patients only one, while in other patients a combination
of factors, may be acting to sustain the elevation of arterial pressure. There-
fore, in order to lower the pressure in some patients it may be necessary to
correct only one of these factors, while in others it may require a number
of different therapeutic procedures applied successively or simultaneously.
It long has been recognized that every psychic tendency seeks adequate
bodily expression and that inner tension which cannot be released through
ordinary channels may manifest itself in the circulatory system by the
response of hypertension. Stewart Wolf," Weiss and English,' and others
have demonstrated that latent hostility and repressed aggression may cause
hypertension, which is improved or may disappear entirely following ven-
tilation of the latent hostility and by understanding or airing of the
repressed aggression. Thus, anxiety may be closely related to hypertension.
It has been said frequently that one of the worst possible disfavors to the
hypertensive patient was the introduction of the sphygmomanometer into
medicine. There is little doubt that the public has become so blood pressure
conscious that they can be scared into hypertension by the "alarm reaction"
on the physician's face or the thoughtless question, "Has anyone in your
family died of high blood pressure?" It has been recognized for decades
that the initial pressure taken in the physician's office or in the hospital may
be elevated purely on the basis of apprehension. This is doubly true if the
physician has an abrupt manner or is hurried or unsympathetic in his
approach to the patient. An understandable reaction on the part of the
patient to a particularly aggressive physician or nurse is an instantaneous,
and at times sustained, pressor reaction of his entire central and autonomic
nervous systems. In attempting to offset this reaction, it is wise to point
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out to the patient that there is little significance to the level of hypertension
since some patients have hypertension for twenty to forty years without any
interference with their normal existence. Depending on the physician's
knowledge of his patient, it may be unwise for him to acquaint the patient
with the fact that hypertension only becomes objectively troublesome when
it is complicated by failure in the retinal, cerebral, coronary, or renal circu-
lation. We feel quite certain that there must be many hypertensives, the
majority of them females but a fair number of them males, who are asymp-
tomatic and getting along quite well because they have not been subjected
to the sphygmomanometer.
For variable periods of time, George Crile,8' Adson and Craig,2 Page and
Heuer,M and Peet,28 among many other surgeons, were enthusiastic regard-
ing the surgical treatment of hypertension. Smithwick7 ' has been the more
recent apostle of this form of therapy. As a result of almost twenty years of
this combined surgical enthusiasm for sympathectomy, literally thousands
of patients have been more or less completely separated from their autono-
mic nervous systems, if not always from their hypertension. It cannot be
denied that out of all of this mutilation of the sympathetic nervous system
there emerges occasionally a "miraculous cure," but we have observed none
in our series of fifty-two patients followed postoperatively for periods of
five to fifteen years. All too frequently we have had the experience of seeing
patients operated upon elsewhere and declared "cures" whose pressure,
when we measured it later, was extremely high, often as high as the
sphygmomanometer could register. This does not indicate dishonesty on the
part of our surgical colleagues but it does mean, quite frequently, that these
patients drift away from the surgeon and are followed for longer periods of
years by the internist or the family physician.
CASE REPORT
Each time I am tempted to become enthusiastic about a new and untried
form of surgical or medical therapy, I remember the rather sizable group of
patients who have refused surgical treatment for their hypertension and
have been unwilling to accept any extreme form of treatment. From this
large group I wish to record a patient whose course has defied in every
respect the expected outcome of her disorder.
B.C.H., a 37-year-old graduate nurse was first seen by me in 1936 within several
days after an ophthalmologist, in checking her eyes for new glasses, had told her that
she had "the eyegrounds of a 70-year-old." This obviously was quite upsetting to the
patient because her mother and father, two brothers, and a sister had died under the
age of forty of complications of hypertension. Her blood pressure at that time was
160/90, but the remainder of her examination was negative. Her chest X-ray was
normal for heart size and shape and her E.K.G. was normal. Later that year at the
time of surgical treatment for a calcified bursitis her blood pressure was found to be
190/100. Because of her very significant family history of hypertension she was offered
sympathetic resection but this she refused. One year later (1937) she experienced a
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mild mental depression and her pressure remained at a constant level of 220/120. In
1938, having recovered from her depression, a new position was found with a lesser
degree of physical work and a decreased amount of emotional pressure. With this new
position, very mild sedation, and frequent opportunities for her to talk over her prob-
lems, her pressure fell gradually to 160/90 in the next six years. During the past eight
years since 1944, her pressure has ranged from 140/90 to 150/90 with several readings
having been found as low as 130/85. She works regularly and has been quite unre-
stricted in her activities during the past ten years and is now fifty-three years of age.
Her heart is normal size and her E.K.G. is normal; her renal function is normal and
there have been no hemorrhages or exudate in the eyegrounds.
Study in Progress
We at the present time are in the process of carefully selecting another
group of forty to fifty patients who have not been offered surgery or who
have refused surgery. We are attempting, in so far as it is possible, to have
this group parallel the surgically treated group in age, sex, level of hyper-
tension and proportional number with "malignant" hypertension.
CONCLUSION
Despite our youthful enthusiasm at the time of our previous report in
1941,20 we stated that our surgically treated hypertensive patients were "too
few to have any statistical significance" and concluded that "the surgical
treatment of hypertension, by means of bilateral subdiaphragmatic extra-
peritoneal resection of the splanchnic nerves, celiac ganglion, and the upper
three or four lumbar sympaihetic ganglions, seems to give palliative results
rather than effecting a cure." Now, eleven years later, as we report on the
follow-up of the survivors among the original twelve patients and add forty
more patients who were surgically treated by the more extensive thoraco-
lumbar sympathetic resection, between 1940 and 1947, we can still say that
the surgical therapy of hypertension, in our experience, does not offer a
cure. We can also add sadly that, in our opinion, "the game is not worth
the candle"!
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